Does a 90-day plan guarantee that a clinic can launch in 90 days?

No. Ninety days is the implementation window for organizing and testing the operating system. Timing depends on the clinic's starting point, professional reviews, jurisdiction, partner readiness, staffing, and the gaps uncovered during diligence.

Does the readiness score prove compliance?

No. It is an internal planning tool only. It does not replace legal advice, clinical review, licensing review, pharmacy diligence, or any required approval.

Should we choose products before building the workflow?

Product and patient-care decisions belong with the licensed clinical team. Operationally, the clinic should first know who owns each decision, what review is required, and how sourcing, consultation, follow-up, support, and escalation will work.

What should front-desk staff be trained to do?

They should confidently explain the booking process, use approved non-clinical language, protect patient information, and route clinical questions to the licensed team. They should not improvise treatment, outcome, safety, or suitability claims.

What metrics matter during a controlled launch?

Start with qualified inquiries, booked consultations, completed consultations, starts, response time, follow-up completion, source, and closed-lost reason. Leadership should also track staff capacity and the full cost to operate the workflow.

Where should a clinic verify current compounding information?

Start with FDA's Human Drug Compounding resources and the relevant state authorities, then have qualified clinical and legal professionals apply the current rules to the clinic's facts. Do not rely on a vendor page or an old launch document as the final authority.

Clinic Peptide Program Launch Readiness Guide

A clinic is not launch-ready because it has a product list or a willing provider. It is ready when the people responsible for clinical decisions, sourcing, staff execution, patient communication, measurement, and escalation are named, aligned, and working from documented processes.

The launch-readiness check

Answer each item with yes, no, or not yet verified. A confident yes should point to a person, document, system, or completed review. If it cannot, treat it as a no.

An accountable program owner has authority over the 90-day launch.
A licensed clinical lead owns patient-care decisions and escalation paths.
Qualified legal or compliance counsel has identified the reviews required for each operating state.
The clinic has documented how each pharmacy or supplier relationship will be evaluated and approved.
Patient-facing staff know what they may say, what they may not say, and when to escalate a question.
The intake, consultation, payment, follow-up, and support handoffs each have a named owner.
The clinic can measure inquiries, booked consultations, completed consultations, starts, and follow-up without relying on memory.
Leadership has approved a conservative financial model using clinic-specific costs and assumptions.

Days 1–30: establish control

1. Name the decision owners

Create a one-page responsibility map. At minimum, name the program owner, clinical lead, compliance contact, operations owner, front-desk lead, finance owner, and measurement owner. One person can hold more than one role, but no responsibility should be ownerless.

2. Build the evidence folder

Keep source documents, partner information, review notes, approved patient communications, staff scripts, change history, and open questions in one controlled location. Record who approved each item and when it should be reviewed again.

For a blank decision log, use the clinic launch workboard to record open decisions, accountable owners, links to approved evidence, and next review dates. The article includes instructions and a downloadable CSV worksheet.

3. Document sourcing questions before comparing vendors

Do not reduce sourcing diligence to a logo, a sales claim, or a price sheet. Build a repeatable review with clinical and legal input. Ask what entity prepares or dispenses the product, what registrations or licenses are relevant, where service is available, how prescriptions and patient-specific orders are handled, what documentation is supplied, and how recalls or quality events are communicated.

Route every sourcing statement and patient-facing product description through the clinic's qualified review process. Record the evidence reviewed, the exact wording approved, the approver, and the next review date.

Days 31–60: make the workflow executable

4. Map the patient journey

Map the path from first inquiry through consultation, any subsequent service, payment, follow-up, support, and escalation. For every handoff, define the owner, expected response time, system of record, and failure path. The clinical lead determines the patient-care content within that workflow.

5. Train for boundaries, not memorized promises

Front-desk and marketing teams need approved language for what the clinic offers, how to book, and where clinical questions go. They also need a clear stop list. Outcome, safety, equivalence, approval, and patient-suitability statements should not be improvised. Route proposed public wording and its evidence package to qualified reviewers before publication.

Can staff explain the next step without making a clinical recommendation?
Can staff recognize a clinical question and route it immediately?
Are website, email, SMS, and social messages using the same approved language?
Can leadership identify the evidence behind every objective health claim?
Is there a documented process for correcting or withdrawing outdated copy?

6. Install measurement before launch

Define the funnel before traffic arrives: qualified inquiry, booked consultation, completed consultation, service start, follow-up milestone, and closed-lost reason. Track counts and conversion rates by source. Keep clinical records in the appropriate clinical system and limit marketing analytics to the minimum data needed for business measurement.

Days 61–90: validate the system

7. Run a controlled launch

Start with a volume the existing team can support. Hold a weekly operating review that covers unresolved questions, handoff failures, response times, staff feedback, measurement quality, and any patient communication that needs clinical or legal review. Do not use early anecdotes as proof of outcomes.

8. Approve the economics with real inputs

Model the program using the clinic's own acquisition costs, consultation capacity, staff time, partner costs, payment fees, support load, refunds, overhead, and conservative conversion assumptions. Use a base case, downside case, and capacity ceiling. Revenue without labor and risk costs is not a useful operating model.

9. Decide whether to expand, repair, or pause

At day 90, leadership should make an explicit decision. Expand only if the control system works, the team can sustain the workload, measurement is trustworthy, and required professional reviews remain current. Otherwise, repair the weak stage or pause the program. A disciplined pause is better than scaling an unclear process.

A simple internal readiness score

Score each category from 0 to 2. Zero means unresolved, one means documented but untested, and two means documented, owned, and tested. This is an internal planning heuristic, not a compliance certification or clinical credential.

GovernanceOwners, approvals, review calendar0 · 1 · 2

Professional reviewClinical, legal, and jurisdiction-specific questions0 · 1 · 2

Sourcing diligencePartner review, documentation, escalation0 · 1 · 2

OperationsHandoffs, systems, training, support0 · 1 · 2

MeasurementFunnel events, finance model, decision cadence0 · 1 · 2

8–10: ready for a controlled launch, subject to required professional approvals.
5–7: close the named gaps before increasing demand.
0–4: pause launch activity and establish the operating foundation.

What Revival RX Partners helps build

The 90-Day Peptide Revenue System is an implementation engagement for clinic owners who need an accountable operating plan. The work centers on program structure, partner coordination, staff enablement, workflow execution, and measurement. Clinical judgment, legal advice, prescribing, dispensing, and patient-care decisions remain with the appropriately licensed professionals and entities responsible for them.

FAQ

Common questions.

Does a 90-day plan guarantee that a clinic can launch in 90 days?
No. Ninety days is the implementation window for organizing and testing the operating system. Timing depends on the clinic's starting point, professional reviews, jurisdiction, partner readiness, staffing, and the gaps uncovered during diligence.
Does the readiness score prove compliance?
No. It is an internal planning tool only. It does not replace legal advice, clinical review, licensing review, pharmacy diligence, or any required approval.
Should we choose products before building the workflow?
Product and patient-care decisions belong with the licensed clinical team. Operationally, the clinic should first know who owns each decision, what review is required, and how sourcing, consultation, follow-up, support, and escalation will work.
What should front-desk staff be trained to do?
They should confidently explain the booking process, use approved non-clinical language, protect patient information, and route clinical questions to the licensed team. They should not improvise treatment, outcome, safety, or suitability claims.
What metrics matter during a controlled launch?
Start with qualified inquiries, booked consultations, completed consultations, starts, response time, follow-up completion, source, and closed-lost reason. Leadership should also track staff capacity and the full cost to operate the workflow.
Where should a clinic verify current compounding information?
Start with FDA's Human Drug Compounding resources and the relevant state authorities, then have qualified clinical and legal professionals apply the current rules to the clinic's facts. Do not rely on a vendor page or an old launch document as the final authority.

Keep reading

Resource503A vs. 503BA clinic-level overview of two federal compounding pathways.

ProgramThe 90-day systemSee how the implementation engagement is structured.

StandardsCompliance postureUnderstand the boundaries built into the operating model.

Your patients are already asking about peptides.Make sure your clinic is ready to answer.

Build and launch your peptide program with Revival RX Partners in 90 days.

Important

Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.